
|Articles|December 30, 2022
Calyx Acquired by CapVest/GLO Healthcare
The financial transaction details pertaining to the eClinical technology provider's deal were not disclosed.
Advertisement
GLO Healthcare, a healthcare platform created by private equity investor CapVest Partners LLP, has completed the acquisition of Calyx, an software and services provider of medical imaging, IRT, CTMS, RIM and EDC for the clinical trials industry. The terms of the transaction are not being disclosed. Calyx will join GLO’s development and delivery of diagnostic testing for major cancers and other diseases.
Read more about
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5



